298 related articles for article (PubMed ID: 22422535)
1. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Repletion in Kidney Stone Formers: A Randomized Controlled Trial.
Ferroni MC; Rycyna KJ; Averch TD; Semins MJ
J Urol; 2017 Apr; 197(4):1079-1083. PubMed ID: 27765695
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic effects of Cholecalciferol supplementation in kidney stone formers with vitamin D deficiency].
Vitale C; Tricerri A; Bermond F; Fabbrini L; Guiotto C; Marangella M
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234237
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?
Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ
Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and kidney stone disease.
Tang J; Chonchol MB
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):383-9. PubMed ID: 23739765
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis.
Eisner BH; Thavaseelan S; Sheth S; Haleblian G; Pareek G
Urology; 2012 Nov; 80(5):1007-10. PubMed ID: 22698470
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women.
Penniston KL; Jones AN; Nakada SY; Hansen KE
BJU Int; 2009 Nov; 104(10):1512-6. PubMed ID: 19389005
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
[TBL] [Abstract][Full Text] [Related]
11. Normocalcemic hyperparathyroidism in patients with recurrent kidney stones: a disease entity or vitamin D deficiency?
Pipili C; Sekecioglu N; Oreopoulos DG
Clin Nephrol; 2012 May; 77(5):352-7. PubMed ID: 22551880
[TBL] [Abstract][Full Text] [Related]
12. Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.
Kim WT; Kim YJ; Yun SJ; Shin KS; Choi YD; Lee SC; Kim WJ
Yonsei Med J; 2014 Sep; 55(5):1326-32. PubMed ID: 25048492
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
14. Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens.
Pappa HM; Mitchell PD; Jiang H; Kassiff S; Filip-Dhima R; DiFabio D; Quinn N; Lawton RC; Varvaris M; Van Straaten S; Gordon CM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2134-42. PubMed ID: 22456619
[TBL] [Abstract][Full Text] [Related]
15. Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial.
Sardari Masihi L; Borumandnia N; Taheri M; Basiri A; Imani H; Jalali S; Tavasoli S
Eur J Med Res; 2023 Jul; 28(1):246. PubMed ID: 37481570
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D, Hypercalciuria and Kidney Stones.
Letavernier E; Daudon M
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
[TBL] [Abstract][Full Text] [Related]
17. Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease.
Simek RZ; Prince J; Syed S; Sauer CG; Martineau B; Hofmekler T; Freeman AJ; Kumar A; McElhanon BO; Schoen BT; Tenjarla G; McCracken C; Ziegler TR; Tangpricha V; Kugathasan S
J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):252-8. PubMed ID: 26196201
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease.
Moe SM; Saifullah A; LaClair RE; Usman SA; Yu Z
Clin J Am Soc Nephrol; 2010 Feb; 5(2):299-306. PubMed ID: 20056760
[TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.
McMullan CJ; Borgi L; Curhan GC; Fisher N; Forman JP
J Hypertens; 2017 Apr; 35(4):822-829. PubMed ID: 28033130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
